Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Market watchers are predicting strong performance driven by the continued success of Lilly's blockbuster drugs, particularly recent launches. However, there are also concerns about potential challenges from gener